{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:27:08Z","timestamp":1793165228763,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.diabet.2012.01.002","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T19:02:20Z","timestamp":1330974140000},"page":"193-204","source":"Crossref","is-referenced-by-count":139,"title":["Diabetes and mucormycosis: A complex interplay"],"prefix":"10.1016","volume":"38","author":[{"given":"B.","family":"Rammaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Poir\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2012.01.002_bib0005","unstructured":"WHO. Diabetes [Internet]; available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs312\/en\/index.html [cited 2011 Mar 14]."},{"key":"10.1016\/j.diabet.2012.01.002_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/469478a","article-title":"Medicine: diabetes in India","volume":"469","author":"Diamond","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2012.01.002_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.transproceed.2010.09.098","article-title":"Epidemiology and costs of diabetes","volume":"43","author":"Bruno","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.diabet.2012.01.002_bib0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/597039","article-title":"Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","article-title":"Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole","volume":"50","author":"Chamilos","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0030","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1128\/JCM.42.11.5400-5402.2004","article-title":"Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin","volume":"42","author":"Luk\u00e1cs","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1574-6968.2007.00661.x","article-title":"Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive zygomycetes","volume":"270","author":"Galg\u00f3czy","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.diabet.2012.01.002_bib0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1086\/600825","article-title":"Are statins applicable for the prevention and treatment of zygomycosis?","volume":"49","author":"Galg\u00f3czy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkp430","article-title":"Forty-one recent cases of invasive zygomycosis from a global clinical registry","volume":"65","author":"R\u00fcping","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0055","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib12","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the \u201cRetroZygo study\u201d (2005-2007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin infect dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13693780500464930","article-title":"The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus","volume":"44","author":"Chakrabarti","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0070","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0075","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/INF.0b013e318062115c","article-title":"Zygomycosis in children: a systematic review and analysis of reported cases","volume":"26","author":"Zaoutis","year":"2007","journal-title":"Pediatr Infect Dis. J"},{"key":"10.1016\/j.diabet.2012.01.002_bib16","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"54","author":"Rammaert","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0085","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0090","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0095","first-page":"207","article-title":"Mucormycosis in hematologic patients","volume":"89","author":"Pagano","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.diabet.2012.01.002_bib0100","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1600-6143.2006.01496.x","article-title":"Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature","volume":"6","author":"Almyroudis","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.diabet.2012.01.002_bib0105","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/00007611-198911000-00024","article-title":"Cellulitis caused by Rhizomucor pusillus in a diabetic patient receiving continuous insulin infusion pump therapy","volume":"82","author":"Wickline","year":"1989","journal-title":"South Med J"},{"key":"10.1016\/j.diabet.2012.01.002_bib0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/13693780310001644644","article-title":"Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient","volume":"42","author":"Quinio","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0115","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.jinf.2005.03.010","article-title":"A fatal case of disseminated zygomycosis associated with the use of blood glucose self-monitoring equipment","volume":"51","author":"Hampson","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0120","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1196\/annals.1372.010","article-title":"Mucormycosis mimicks sinusitis in a diabetic adult","volume":"1084","author":"Szalai","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.diabet.2012.01.002_bib0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/joms.2001.23407","article-title":"A fatal outcome from rhinocerebral mucormycosis after dental extractions: a case report","volume":"59","author":"Kim","year":"2001","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.diabet.2012.01.002_bib0130","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00007611-198109000-00030","article-title":"Cunninghamella bertholletiae wound infection of probable nosocomial origin","volume":"74","author":"Boyce","year":"1981","journal-title":"South Med J"},{"key":"10.1016\/j.diabet.2012.01.002_bib0135","first-page":"298","article-title":"Cutaneous mucormycosis in a diabetic woman. Diagnostic and therapeutic problems","volume":"5","author":"Eschard","year":"1984","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.diabet.2012.01.002_bib0140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JCM.41.2.783-788.2003","article-title":"Apophysomyces elegans: an emerging zygomycete in India","volume":"41","author":"Chakrabarti","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3928\/0147-7447-19990401-16","article-title":"Mucormycosis osteomyelitis in the hand","volume":"22","author":"Stevanovic","year":"1999","journal-title":"Orthopedics"},{"key":"10.1016\/j.diabet.2012.01.002_bib0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1590\/S0036-46651985000400008","article-title":"Subcutaneous mucormycosis caused by Rhizopus oryzae probable nosocomial acquired infection","volume":"27","author":"Telles Filho","year":"1985","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.diabet.2012.01.002_bib0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/clinids\/12.5.19","article-title":"Peritonitis due to Rhizopus in a patient undergoing continuous ambulatory peritoneal dialysis","volume":"13","author":"Branton","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09273940601186974","article-title":"Mucormycosis endophthalmitis after cataract surgery","volume":"15","author":"Mohadjer","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.diabet.2012.01.002_bib0165","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0886-3350(98)80302-7","article-title":"Postoperative Rhizopus scleritis in a diabetic man","volume":"24","author":"Locher","year":"1998","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.diabet.2012.01.002_bib0170","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1590\/S0100-879X2006005000143","article-title":"Neutrophil function and metabolism in individuals with diabetes mellitus","volume":"40","author":"Alba-Loureiro","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.diabet.2012.01.002_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dmrr.682","article-title":"Common infections in diabetes: pathogenesis, management and relationship to glycaemic control","volume":"23","author":"Peleg","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2012.01.002_bib0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.diabet.2007.10.001","article-title":"Impaired cytokine production by peripheral blood mononuclear cells in type-1 diabetic patients","volume":"33","author":"Foss","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2012.01.002_bib0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI111395","article-title":"Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defence against Rhizopus","volume":"74","author":"Waldorf","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2012.01.002_bib0190","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diabet.2012.01.002_bib0195","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/IAI.73.2.778-783.2005","article-title":"Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro","volume":"73","author":"Ibrahim","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.diabet.2012.01.002_bib0200","first-page":"243","article-title":"Pulmonary defence mechanisms against opportunistic fungal pathogens","volume":"47","author":"Waldorf","year":"1989","journal-title":"Immunol Ser"},{"key":"10.1016\/j.diabet.2012.01.002_bib0205","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1128\/IAI.63.11.4489-4494.1995","article-title":"Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies","volume":"63","author":"Jorens","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.diabet.2012.01.002_bib0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/00362178485380171","article-title":"Mucormycotic infection in mice following prolonged incubation of spores in vivo and the role of spore agglutinating antibodies on spore germination","volume":"22","author":"Waldorf","year":"1984","journal-title":"Sabouraudia"},{"key":"10.1016\/j.diabet.2012.01.002_bib0215","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1128\/IAI.38.3.1217-1222.1982","article-title":"Mucorales species activation of a serum leukotactic factor","volume":"38","author":"Marx","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.diabet.2012.01.002_bib0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00362178285380321","article-title":"Murine model of pulmonary mucormycosis in cortisone-treated mice","volume":"20","author":"Waldorf","year":"1982","journal-title":"Sabouraudia"},{"key":"10.1016\/j.diabet.2012.01.002_bib0225","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1084\/jem.110.6.845","article-title":"The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits","volume":"110","author":"Sheldon","year":"1959","journal-title":"J Exp Med"},{"key":"10.1016\/j.diabet.2012.01.002_bib0230","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/IAI.38.3.1123-1129.1982","article-title":"Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis","volume":"38","author":"Chinn","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.diabet.2012.01.002_bib0235","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.38.1.292-297.1982","article-title":"Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro","volume":"38","author":"Diamond","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.diabet.2012.01.002_bib0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/IAI.44.1.194-195.1984","article-title":"Cerebral mucormycosis in diabetic mice after intrasinus challenge","volume":"44","author":"Waldorf","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.diabet.2012.01.002_bib0245","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/428503","article-title":"Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes","volume":"191","author":"Gil-Lamaignere","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0250","first-page":"313","article-title":"Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis","volume":"91","author":"Diamond","year":"1978","journal-title":"Am J Pathol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0255","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"Chamilos","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0260","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1073\/pnas.0709578105","article-title":"Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis","volume":"105","author":"Chamilos","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.diabet.2012.01.002_bib0265","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/diab.22.11.847","article-title":"Thirty-two fatal cases of severe diabetic ketoacidosis, including a case of mucormycosis","volume":"22","author":"Beigelman","year":"1973","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.01.002_bib0270","first-page":"1507","article-title":"Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin","volume":"36","author":"Abe","year":"1986","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.diabet.2012.01.002_bib0275","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diabetes.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.01.002_bib0280","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0285","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2958.2010.07234.x","article-title":"The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis","volume":"77","author":"Ibrahim","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0290","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2012.01.002_bib0295","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/605607","article-title":"Potential antifungal effects of human platelets against zygomycetes in vitro","volume":"200","author":"Perkhofer","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0300","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/dmrr.1173","article-title":"Alterations of platelet biochemical and functional properties in newly diagnosed type 1 diabetes: a role in cardiovascular risk?","volume":"27","author":"Vignini","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2012.01.002_bib0305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TP.0b013e3181dde8fc","article-title":"Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients","volume":"90","author":"Sun","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.diabet.2012.01.002_bib0315","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.diabres.2008.07.011","article-title":"Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients","volume":"82","author":"Turunc","year":"2008","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.diabet.2012.01.002_bib0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1469-0691.2009.02974.x","article-title":"Clinical presentation of zygomycosis","volume":"15","author":"Mantadakis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.diabet.2006.12.001","article-title":"Zygomycosis: an uncommon cause for peripheral facial palsy in diabetes","volume":"33","author":"Meas","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2012.01.002_bib0330","first-page":"712","article-title":"Multiple cranial nerve palsies associated with type-2 diabetes mellitus","volume":"47","author":"Singh","year":"2006","journal-title":"Singapore Med J"},{"key":"10.1016\/j.diabet.2012.01.002_bib0335","first-page":"E360","article-title":"Maxillary necrosis by mucormycosis. a case report and literature review","volume":"12","author":"Auluck","year":"2007","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.diabet.2012.01.002_bib0340","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1111\/j.1439-0507.2009.01831.x","article-title":"Sudden vision loss caused by rhino-orbital zygomycosis in diabetic patients: case series","volume":"54","author":"Chander","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.diabet.2012.01.002_bib0345","doi-asserted-by":"crossref","first-page":"964","DOI":"10.47102\/annals-acadmedsg.V37N11p964","article-title":"Fungal pan-sinusitis with severe visual loss in uncontrolled diabetes","volume":"37","author":"Chua","year":"2008","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.diabet.2012.01.002_bib0350","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2214\/ajr.168.6.9168721","article-title":"Pulmonary mucormycosis: radiologic findings in 32 cases","volume":"168","author":"McAdams","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0355","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: the last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diabet.2012.01.002_bib0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00270-005-0328-1","article-title":"Subclavian artery occlusion and pseudoaneurysm caused by lung apex mucormycosis: successful treatment with transcatheter embolization","volume":"30","author":"Economopoulos","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2005.08.009","article-title":"Pulmonary mucormycosis: two of a kind","volume":"17","author":"Agarwal","year":"2006","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.diabet.2012.01.002_bib0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1469-0691.2009.02979.x","article-title":"Cutaneous zygomycosis","volume":"15","author":"Skiada","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0375","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00405-008-0692-y","article-title":"Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment","volume":"266","author":"Arndt","year":"2009","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0380","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0385","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0390","first-page":"1405","article-title":"Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies","volume":"88","author":"Nosari","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.diabet.2012.01.002_bib0395","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1378\/chest.117.1.279","article-title":"The role of BAL in the diagnosis of pulmonary mucormycosis","volume":"117","author":"Glazer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.diabet.2012.01.002_bib0400","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/194589240101500508","article-title":"Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B","volume":"15","author":"Alobid","year":"2001","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0405","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3174\/ajnr.A1808","article-title":"The Black Turbinate\u201d sign: an early MR imaging finding of nasal mucormycosis","volume":"31","author":"Safder","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0410","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2010.03301.x","article-title":"Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections","volume":"17","author":"Hot","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0415","series-title":"Manual of clinical microbiology","article-title":"Agents of systemic and subcutaneous mucormycosis and entomophthoromycosis","author":"Garcia-Hermoso","year":"2011"},{"key":"10.1016\/j.diabet.2012.01.002_bib0420","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Fl\u00f6rl","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0425","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/13693780701796973","article-title":"Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital","volume":"46","author":"Torres-Narbona","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0430","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1469-0691.2009.02983.x","article-title":"Molecular tools for identification of zygomycetes and the diagnosis of zygomycosis","volume":"15","author":"Dannaoui","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-5-1","article-title":"Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient","volume":"5","author":"Hofman","year":"2010","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0440","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13693780500130341","article-title":"Diagnostic challenge of zygomycosis in compromised hosts","volume":"44","author":"Wang","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0445","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0450","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1469-0691.2009.02989.x","article-title":"Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon","volume":"15","author":"Rapidis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0455","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/sur.2006.039","article-title":"Invasive mucormycosis of the maxillary sinus: extensive destruction with an indolent presentation","volume":"9","author":"Odessey","year":"2008","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.diabet.2012.01.002_bib0460","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.joms.2005.10.017","article-title":"Disseminated rhinocerebral mucormycosis: a case report and review of the literature","volume":"64","author":"O\u2019Neill","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.diabet.2012.01.002_bib0465","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.diabet.2012.01.002_bib0470","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1128\/AAC.47.11.3647-3650.2003","article-title":"Activity of posaconazole in treatment of experimental disseminated zygomycosis","volume":"47","author":"Dannaoui","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0475","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0480","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0485","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkl350","article-title":"Deferiprone iron chelation as a novel therapy for experimental mucormycosis","volume":"58","author":"Ibrahim","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0490","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2012.01.002_bib0495","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/AAC.01577-10","article-title":"Combination therapy of murine mucormycosis or aspergillosis with iron chelation. Polyenes and echinocandins","volume":"55","author":"Ibrahim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0500","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/AAC.47.10.3343-3344.2003","article-title":"Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae","volume":"47","author":"Ibrahim","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0505","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.49.2.721-727.2005","article-title":"Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis","volume":"49","author":"Ibrahim","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0510","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/AAC.01488-07","article-title":"Comparison of lipid amphotericin B preparations in treating murine zygomycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0515","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-0691.2008.01984.x","article-title":"Liposomal amphotericin B: what is its role in 2008?","volume":"14","author":"Lanternier","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0520","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0525","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.01222-09","article-title":"Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis","volume":"54","author":"Lewis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0530","first-page":"1068","article-title":"Mucormycosis in hematologic malignancies: an emerging fungal infection","volume":"85","author":"Nosari","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.diabet.2012.01.002_bib0535","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0540","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s100960100528","article-title":"Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion","volume":"20","author":"Herbrecht","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0545","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/13693780903311944","article-title":"Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases","volume":"48","author":"Shoham","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0550","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1086\/589858","article-title":"Editorial commentary: what is the role of combination therapy in management of zygomycosis?","volume":"47","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0555","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1469-0691.2009.02985.x","article-title":"Current experience in treating invasive zygomycosis with posaconazole","volume":"15","author":"Cornely","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diabet.2012.01.002_bib0560","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik J-AH","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0565","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/AAC.00939-09","article-title":"Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults","volume":"53","author":"Lebeaux","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0570","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.00361-09","article-title":"Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis","volume":"53","author":"Spellberg","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diabet.2012.01.002_bib115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0575","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1179\/joc.2009.21.3.272","article-title":"In vitro antifungal activity of isavuconazole against 345 Mucorales isolates collected at study centers in eight countries","volume":"21","author":"Verweij","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.diabet.2012.01.002_bib0580","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JCM.01420-10","article-title":"Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern","volume":"48","author":"Chakrabarti","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diabet.2012.01.002_bib0585","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabet.2012.01.002_bib0590","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Spellberg","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363612000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363612000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T22:08:55Z","timestamp":1687298935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363612000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1262363612000109"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2012.01.002","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}